Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless ...

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus ...

MONDAY, Nov. 24, 2025 (HealthDay News) — Under current screening guidelines, almost two-thirds of Americans with lung cancer ...

NIPPV is a treatment where a machine is used to help the person breathe. During NIPPV therapy, the person breathes using a mask that forces the air into the lungs, keeping the airways open and ...

The following highlights spotlight the latest advances in gastroenterology, featuring studies and insights presented at this ...

The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K ...

Cold weather brings many exciting things, but it often means the inception of colds, respiratory illness, and even the ...

The US health agency has updated its official website to reflect the vaccine skepticism of a senior Trump official, a move ...

The US health agency has updated its official website to reflect the vaccine skepticism of a senior Trump official, ...

(IN BRIEF) Sandoz has announced the US availability of TYRUKO® (natalizumab-sztn), the first FDA-approved biosimilar to Tysabri® for treating relapsing forms of multiple sclerosis and Crohn’s disease.

Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as ...

Patients recovering from respiratory sepsis vs COVID- or pneumonia-related sepsis face the highest burden of postacute impairments and mortality.